Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Granules Pharmaceuticals Inc. · Unavailable · Reason: Shortage of an active ingredient
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 10/12/2022
- Package NDC
- 70010-113-01
- Generic name
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
- Contact info
- 877-770-3183
- Availability
- Unavailable
- Related info
- Estimated recovery: October 2026
- Update date
- 10/13/2026
- Dosage form
- Tablet
- Company name
- Granules Pharmaceuticals Inc.
- Shortage reason
- Shortage of an active ingredient
- Status
- Current
- Presentation
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA215771
- Brand name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Generic name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Manufacturer name
- Granules Pharmaceuticals Inc.
- Product NDC
- 70010-113, 70010-111, 70010-112, 70010-114, 70010-115, 70010-116, 70010-117
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
- RxCUI
- 541363, 541878, 541892, 577957, 577961, 687043, 1009145
- SPL ID
- 56c7c921-e560-c5ad-e063-6294a90a4c81
- SPL set ID
- b0b4eccc-34c7-483d-966f-82d588358e1b
- Package NDC
- 70010-111-01, 70010-111-03, 70010-112-01, 70010-112-03, 70010-113-01, 70010-113-03, 70010-114-01, 70010-114-03, 70010-115-01, 70010-115-03, 70010-116-01, 70010-116-03, 70010-117-01, 70010-117-03
- UNII
- 6DPV8NK46S, JJ768O327N, O1ZPV620O4, G83415V073